Centiva Capital »

Apogee Therapeutics shares owned by Centiva Capital

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Centiva Capital from 13F filings

Historical chart of Centiva Capital investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Centiva Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Centiva Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.7M 50k 132.73
2024-06-30 $253k 6.4k 39.35

More positions owned by Centiva Capital

NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust St Str Sp Regbnk (KRE)
Vaneck Etf Trust Semiconductr Etf (SMH)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Marvell Technology (MRVL)

View all positions for Centiva Capital

Top funds holding Apogee Therapeutics

VR Adviser
BlackRock
HBK Investments
Vanguard Capital Management
FMR
Henderson Group
Balyasny Asset Management
State Street Corporation
Driehaus Capital Management
Goldman Sachs Group
Glazer Capital
Paradigm Biocapital Advisors
Vanguard Portfolio Management
Millennium Management
Pentwater Capital Management

View all funds holding Apogee Therapeutics